Examkin

Question

Difficulty: HardPharmacokinetic and Pharmacodynamic Principles

A 5858-year-old man with a history of decompensated alcoholic cirrhosis is recovering from surgical repair of a fractured right femur. During the initial postoperative period, his severe pain was well-controlled with scheduled intravenous morphine. His current laboratory results show a serum albumin of 2.62.6 g/dL, total bilirubin of 4.24.2 mg/dL, and an International Normalized Ratio (INR) of 1.91.9. The medical team is preparing to transition him to an oral morphine regimen for discharge to a skilled nursing facility. Morphine is a classic high hepatic extraction ratio medication (EH>0.7E_H > 0.7). Compared to a healthy adult with normal hepatic function, which of the following pharmacokinetic changes is most likely to be observed in this patient upon receiving the oral formulation?

  1. Substantially increased systemic bioavailability due to diminished presystemic biotransformationAnswer
  2. B
    Decreased steady-state volume of distribution secondary to impaired hepatic protein synthesis
  3. C
    Accelerated rate of drug elimination caused by compensatory induction of cytochrome P450 enzymes
  4. D
    Paradoxically increased renal clearance driven by hepatorenal compensatory hemodynamics
  5. E
    Diminished peak plasma concentration (CmaxC_{max}) resulting from delayed gastric emptying

Answer

Substantially increased systemic bioavailability due to diminished presystemic biotransformation
For drugs with a high hepatic extraction ratio (EH>0.7E_H > 0.7), systemic bioavailability is highly dependent on first-pass metabolism. In a patient with normal hepatic function, a large portion of an orally administered dose is metabolized before ever reaching the systemic circulation. However, in decompensated cirrhosis, the destruction of liver parenchyma and the development of extensive portosystemic shunting allow the drug to bypass the liver entirely. This results in a profound decrease in presystemic (first-pass) biotransformation, leading to a massive increase in the absolute bioavailability and peak plasma concentration (CmaxC_{max}) of the parent drug. Consequently, standard oral doses can cause severe and immediate toxicity, such as respiratory depression, in these patients.

Step-by-Step Solution

1
Analyze the pharmacokinetic properties of the drug mentioned in the stem.
Morphine has a high hepatic extraction ratio (EH>0.7E_H > 0.7), meaning it relies heavily on first-pass metabolism when administered orally.
Understanding the baseline pharmacokinetics determines how organ failure will alter systemic exposure.
2
Evaluate the patient's underlying pathophysiology based on history and labs.
The patient has decompensated cirrhosis (low albumin, high bilirubin, elevated INR), characterized by hepatocellular loss and significant portosystemic shunting.
Liver disease alters both intrinsic clearance and hepatic blood flow.
3
Determine the interaction between the disease state and the oral route of administration.
Portosystemic shunting allows the orally absorbed drug to completely bypass the liver's metabolic enzymes before entering the systemic circulation.
Bypassing the liver eliminates the first-pass effect, which is the primary barrier to systemic absorption for high-extraction drugs.
4
Synthesize the expected pharmacokinetic shift.
The absolute bioavailability (FF) and peak plasma concentration (CmaxC_{max}) will be massively increased compared to a healthy patient.
A dose that normally undergoes extensive presystemic biotransformation will now reach the systemic circulation largely intact.

Key Concept

Impact of portosystemic shunting on the oral bioavailability of high hepatic extraction ratio drugs.
Rate this question

Topics

Pharmacokinetic and Pharmacodynamic Principles

More questions from this topic